Healthcare's ongoing shift toward value-based care is a good thing, Joynt Maddox explained, but its implementation has been far from ideal. She also discussed population health, the pandemic, health disparities and the rising influence of private equity investments.

While one of the new devices was developed for the general public, the second was specifically designed for users with type 2 diabetes who do not take insulin.

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery. 

Jagmeet Singh, MD, delivered a keynote address at HRS 2024 on the future of AI in electrophysiology. He spoke to Cardiovascular Business, sharing additional thoughts about the topic.

The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care. 

The group’s work is focused on how signal processing technologies and machine learning can track the health of VADs and the patients who need them. 

Cardiovascular Business spoke with HRS President Kenneth Ellenbogen, MD, about two key initiatives the group is focused on this year.

More than 60% of adults in the United States are expected to have at least one form of cardiovascular disease by 2050, according to new data published by the American Heart Association. Fortunately, evidence does suggest that healthier lifestyles are starting to become more common as time goes on.